STZ - Constellation Brands, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
186.04
+1.72 (+0.93%)
As of 3:26PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close184.32
Open185.55
Bid186.13 x 900
Ask186.16 x 1100
Day's Range185.49 - 188.09
52 Week Range150.37 - 233.10
Volume704,933
Avg. Volume1,883,250
Market Cap35.508B
Beta (3Y Monthly)1.04
PE Ratio (TTM)10.59
EPS (TTM)17.57
Earnings DateJun 28, 2019
Forward Dividend & Yield3.00 (1.63%)
Ex-Dividend Date2019-05-09
1y Target Est221.64
Trade prices are not sourced from all markets
  • Balanced Risk-Reward for Keurig Dr Pepper: Stock Up 18% YTD
    Zacks6 hours ago

    Balanced Risk-Reward for Keurig Dr Pepper: Stock Up 18% YTD

    Keurig Dr Pepper (KDP) gains from long-term strategies and strong market share growth across portfolio. But soft CSD category, higher input costs and currency headwinds are hurting sales.

  • GlobeNewswire6 hours ago

    Constellation Brands CEO Bill Newlands Signs CEO Action for Diversity & Inclusion Pledge

    VICTOR, N.Y., June 20, 2019 -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that that Bill Newlands, president and.

  • Will Corona Keep Constellation Brands Growing?
    Motley Fool20 hours ago

    Will Corona Keep Constellation Brands Growing?

    The Mexican import has been hot, but beer sales are cooling.

  • Canopy Growth Earnings After Bell 6/20: Key Word Growth
    Zacks21 hours ago

    Canopy Growth Earnings After Bell 6/20: Key Word Growth

    CGC analysts are estimating an EPS of -0.17 and revenues of $71 million. Shareholders are voting today on whether to acquire Acreage Holdings, which could propel CGC one way or the other.

  • Can Rite Aid (RAD) Beat on Earnings in Q1 Despite Soft View?
    Zacksyesterday

    Can Rite Aid (RAD) Beat on Earnings in Q1 Despite Soft View?

    Rite Aid's (RAD) first-quarter fiscal 2020 results should gain from growth initiatives, and momentum in retail and pharmacy businesses. However, a bleak outlook raises concerns.

  • General Mills (GIS) to Gain From Blue Buffalo in Q4 Earnings
    Zacksyesterday

    General Mills (GIS) to Gain From Blue Buffalo in Q4 Earnings

    General Mills (GIS) is poised to gain from its core strategies to drive sales growth. Also, its robust cost-saving measures should offer cushion from input cost inflation in Q4 earnings.

  • NIKE (NKE) Q4 Earnings to Suffer From Currency Headwinds
    Zacksyesterday

    NIKE (NKE) Q4 Earnings to Suffer From Currency Headwinds

    NIKE (NKE) boasts an impressive earnings record, driven by solid execution of Consumer Direct Offense. But currency headwinds might play spoilsport in fourth-quarter fiscal 2019.

  • Check Out Kroger's (KR) Probability to Beat in Q1 Earnings
    Zacks3 days ago

    Check Out Kroger's (KR) Probability to Beat in Q1 Earnings

    Kroger (KR) is making investments to expand grocery offerings and e-commerce presence. However, incremental investments may keep margins under pressure.

  • Markit2 days ago

    See what the IHS Markit Score report has to say about Constellation Brands Inc.

    Constellation Brands Inc NYSE:STZ.BView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low but may be increasing Bearish sentimentShort interestThere is no short interest data available for this security. Money flowETF/Index ownership | NeutralAsset inflows and outflows over the last month have been identical. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. STZ.B credit default swap spreads are at their highest levels for the past 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Earnings Will Be Huge for Canopy Growth and Marijuana Stocks
    InvestorPlace2 days ago

    Earnings Will Be Huge for Canopy Growth and Marijuana Stocks

    Marijuana stocks seem a bit wobbly at the moment and Canopy Growth (NYSE:CGC) is no exception. The CGC stock price hasn't tanked, to be sure. Shares in fact still are up a healthy 53% in 2019. But the gains came early. Since late April, Canopy has dropped over 20%.Source: Shutterstock Canopy Growth earnings on Thursday will provide an opportunity to reverse the recent trend. That's true not just for Canopy Growth stock but for the marijuana sector as a whole.The trend in the CGC stock price mirrors that of other widely held pot plays. Investor patience seems a bit thin. Valuations, even with modest declines, remain sky-high. And sector-wide earnings of late haven't been close to good enough.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIf Canopy -- the industry's largest player -- can't deliver, investors are going to wonder who can. And that suggests that the rest of the sector could follow Canopy stock downward. Expectations for Canopy EarningsAnalysts are expecting Canopy Growth to post a reasonably large loss in its fiscal fourth quarter. The current consensus estimate is for a loss of 24 cents CAD per share. * 7 Top-Rated Biotech Stocks to Invest In Today That figure isn't all that meaningful for two reasons. First, the reported figure likely isn't going to be close to that average. Canopy's net income is impacted by changes in fair value of its convertible debt and warrants owned in smaller cannabis companies. In Q3, for instance, Canopy actually reported a large net profit thanks to those accounting effects.Secondly, investors aren't really going to care about profits. Canopy, adjusting for one-time and accounting effects, is going to lose more money than it did a year ago. Since last year's fourth quarter, Canopy has acquired retail chain Hiku, which is not yet profitable. It has invested heavily in production and processing capabilities.These are investments Canopy has to make, decisions that shareholders generally support. There's no point in raising roughly $4 billion from Constellation Brands (NYSE:STZ, NYSE:STZ.B) if the money isn't going to be spent. Canopy has a head start on the industry, and it needs to keep spending to maintain that lead. That's actually the bull case for CGC stock, as I've detailed previously.Rather, investors are going to focus on revenue, pure and simple. Analysts expect revenue to increase 314% year-over-year. There will be some help from Hiku and other acquisitions in that growth but Canopy sales are going to soar. The question for Canopy Growth stock and for the sector will be if they climb high enough. Bad Omens for Canopy Growth StockThe concern for owners of CGC stock heading into earnings is that big growth from other pot plays haven't been big enough. Hexo (NYSEAMERICAN:HEXO) increased revenue nine-fold in its fiscal Q3. HEXO stock fell 13% in the next two sessions after reporting those earnings last week.Cronos (NASDAQ:CRON) earnings last month looked disappointing, though CRON shares have mostly held up. In April, Aphria (NYSE:APHA) stock tanked on an earnings miss with sales up over 500% YOY. Tilray (NASDAQ:TLRY) did a little better, yet its earnings last month largely failed to arrest its equity's long decline. Admittedly, TLRY shares looked awfully bubbly last year.Among the most widely held marijuana stocks, there hasn't been a recent earnings report that investors have truly cheered. And so investors betting on an increase in the CGC stock price next week are betting against the trend. Not Just the CGC Stock PriceThat string of poorly (or at least coolly) received earnings reports is why Canopy earnings are so important to the sector. There simply hasn't been much good news. Sales in Canada aren't growing, though supply constraints are an issue. Movement in the U.S. has been essentially nonexistent since the farm bill was passed in December.From a short-term standpoint, then, Canopy earnings are the last major catalyst for the sector for some time. We're probably talking close to two months. In a broad market that seems a little prone to panic and subsequent profit-taking, that's a potential problem.Therefore, Canopy earnings need to be -- and will be -- watched closely by the entire industry. If Canopy Growth stock sells off on Friday after Thursday evening's report, it's unlikely to be the only one to do so.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * The 7 Best Tech Stocks to Buy for the Second Half of 2019 * 7 Top-Rated Biotech Stocks to Invest In Today * 4 Semiconductor Stocks to Sell Compare Brokers The post Earnings Will Be Huge for Canopy Growth and Marijuana Stocks appeared first on InvestorPlace.

  • Amid A Pot Stock Boom, I Have Misgivings About Aurora Cannabis Stock
    InvestorPlace2 days ago

    Amid A Pot Stock Boom, I Have Misgivings About Aurora Cannabis Stock

    Aurora Cannabis (NYSE:ACG) isn't consistently profitable and has failed to meet Wall Street analysts' earnings estimates in three out of the past four quarters. Like other pot shares, ACG stock is on a tear, up more than 50% since the start of the year as investors bet that better times lie ahead.Source: Shutterstock However, expectations for Aurora stock don't appear to be justified by the fundamentals. The company's penchant for dilutive acquisitions is particularly troubling. Massive DilutionAs of the latest quarter, ACB had had more than 1 billion shares outstanding, more than twice the 478 million shares it had a year earlier. Rival Canopy Growth's (NYSE:CGC) share count is about 238 million. Fortune 500 stalwarts such as CBS (NYSE:CBS) (351.9 million), Southwest Airlines (NYSE:LUV) (543.7 million) and McDonald's (NYSE:MCD) (763.6 million), each have fewer shares outstanding than ACB.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 High-Quality Cheap Stocks to Buy With $10 Let's not forget the options to purchase 19.96 million ACB shares awarded in March to billionaire Nelson Peltz when Aurora named him as a strategic advisor. Though Peltz certainly has the connections to make things happen for ACB, that award is still massive since the company's current top shareholder Vanguard "only" had 20.3 million shares, as of the end of 2018. Profitability StrugglesMeanwhile, ACB is struggling to achieve consistent profitability. Wall Street analysts are expecting the red ink to continue through at least 2020. They have an average price target on the stock of $14.27, a potential upside of 40% for reasons that elude me.A glut in the Canadian pot market will keep prices depressed for the next two to three years just as ACB ramps up production. While I realize that ACB aims to push down prices, it seems that the plan may work too well.Demand also hasn't been robust. According to Health Canada, total sales of dried cannabis grew 7% to 16,488 kilograms between January 1 and March 31 compared with October 16 to December 31, 2018. The total inventory of weed was 30,802 kilograms, as of the end of March, nearly twice the 18,940 kilograms at the end of December 2018. Negative View On BeveragesSpeaking during the company's recent earnings conference call, chief executive Terry Booth surprised investors with his negative comments regarding the demand for cannabidiol (CBD)-infused beverages given the reports that his company held talks with Coca-Cola (NYSE:KO) about a partnership. * 10 Stocks to Buy That Wall Street Expects to Soar for the Rest of 2019 Other companies including Canopy, are more optimistic about the potential for CBD, which lacks the THC compound that makes users high, in beverages. Constellation Brands (NYSE:STZ) invested $4 billion in CGC last year. Anheuser-Busch InBev (NYSE:BUD) teamed up with Canadian pot producer Tilray (NASDAQ: TLRY) on a $100 million initiative to research uses of CBD in non-alcoholic beverages. Heineken's Lagunitas brewery released a non-alcoholic THC-infused beer called Hi-Fi Hops last year. Molson Coors (NYSE:TAP) joined forces with Quebec-based cannabis company HEXO to develop non-alcoholic beverages. Bottom Line on ACB StockThough I had some concerns about Canopy Growth, I like those shares more than ACB stock. Canopy's partnership with STZ gives it financial flexibility that Aurora Cannabis lacks. If you want to buy stock in the highly risky legal pot sector, there are better choices than ACB.-Jonathan Berr doesn't own shares in any of the stocks discussed in this post. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * The 7 Best Tech Stocks to Buy for the Second Half of 2019 * 7 Top-Rated Biotech Stocks to Invest In Today * 4 Semiconductor Stocks to Sell Compare Brokers The post Amid A Pot Stock Boom, I Have Misgivings About Aurora Cannabis Stock appeared first on InvestorPlace.

  • Is 2019 the Year Craft Beer Sales Turn Negative?
    Motley Fool3 days ago

    Is 2019 the Year Craft Beer Sales Turn Negative?

    Industry growth has been in everything but beer.

  • Zacks3 days ago

    Here's Why Boston Beer Stands Out From Alcohol-Beverage Peers

    Boston Beer (SAM) gains from momentum in shipment volume and depletion, driven by its three-point growth plan. This places it ahead of peers in an otherwise struggling alcohol industry.

  • Top Wine Stocks for 2019
    Investopedia4 days ago

    Top Wine Stocks for 2019

    As more wine companies go public, and millennials replace aging generations, the market could see significant upside despite a lackluster 2018.

  • The 5 Most Profitable Pot Stocks on the Planet
    Motley Fool4 days ago

    The 5 Most Profitable Pot Stocks on the Planet

    Most cannabis companies are losing money. These aren't.

  • Better Buy: Canopy Growth vs. Scotts Miracle-Gro
    Motley Fool4 days ago

    Better Buy: Canopy Growth vs. Scotts Miracle-Gro

    Which stock wins in a battle between the biggest cannabis producer by market cap and the biggest supplier to the cannabis industry?

  • The Best Cannabis Stock to Buy in June
    Motley Fool5 days ago

    The Best Cannabis Stock to Buy in June

    This industry leader can help you earn a marijuana-fueled fortune.

  • What Type Of Shareholder Owns Constellation Brands, Inc.'s (NYSE:STZ)?
    Simply Wall St.5 days ago

    What Type Of Shareholder Owns Constellation Brands, Inc.'s (NYSE:STZ)?

    If you want to know who really controls Constellation Brands, Inc. (NYSE:STZ), then you'll have to look at the makeup...

  • Constellation Brands (STZ) Stock Sinks As Market Gains: What You Should Know
    Zacks7 days ago

    Constellation Brands (STZ) Stock Sinks As Market Gains: What You Should Know

    Constellation Brands (STZ) closed at $189.18 in the latest trading session, marking a -0.07% move from the prior day.

  • GuruFocus.com8 days ago

    Bill Nygren Loads Up on Constellation Brands, S&P Global

    Guru releases 1st-quarter portfolio

  • Aluminum Tariff Lift & More Factors to Keep Aiding AB InBev
    Zacks8 days ago

    Aluminum Tariff Lift & More Factors to Keep Aiding AB InBev

    AB InBev (BUD) keeps the momentum alive on robust sales trend, growth of global brands and strong forward outlook. Additionally, the recent lifting of aluminum tariffs is likely to aid performance.

  • 3 Stocks Poised to Benefit From Scrapped Mexican Tariffs
    Investopedia9 days ago

    3 Stocks Poised to Benefit From Scrapped Mexican Tariffs

    These three stocks have significant exposure to Mexico and should benefit from dropped tariff plans.